Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01880437
Title A Study of Vismodegib in Patients With Relapsed/Refractory Acute Myelogenous Leukemia and Relapsed Refractory High-Risk Myleodysplastic Syndrome
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche

acute myeloid leukemia

bone marrow cancer


Cytarabine + Vismodegib

Age Groups: adult
Covered Countries USA | CAN

No variant requirements are available.